Ari Maizel
Executive Vice President and Head of Commercial
Other
Analyst — CRO
Earnings-call appearances
-
Axsome Therapeutics, Inc. Q4 FY2025 Earnings Call2026-01-12
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-03
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-04
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2024 Earnings Call2025-01-13
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-06
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2023 Earnings Call2024-01-04
Axsome Therapeutics, Inc. (AXSM)